Literature DB >> 6114000

Parallel stimulation of ACTH, beta-LPH + beta-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in culture.

V Raymond, J Lépine, V Giguère, J C Lissitzky, J Côté, F Labrie.   

Abstract

Characteristics of the alpha-adrenergic stimulation of ACTH, beta-endorphin + beta-LPH and alpha-MSH release were studied in rat anterior pituitary cells in primary culture. Parallel changes of ACTH, beta-endorphin + beta-LPH and alpha-MSh release were found under all stimulatory and inhibitory conditions by natural and synthetic catecholamine agonists and antagonists. (-)Epinephrine and (-)norepinephrine lead to a 8--10-fold stimulation of peptide release at ED50 values of 20 and 90 nM, respectively. The stereoselectivity of the alpha-adrenergic stimulatory action on peptide release is indicated by a 100-fold higher activity of (-)- than (+)norepinephrine while (-)epinephrine is 10 times more potent than the corresponding (+) stereoisomer. The involvement of a typical alpha-adrenergic mechanism in the control of release of ACTH, beta-endorphin and related peptides in rat anterior pituitary gland is indicated by the following order of potency of a series of catecholaminergic agents (ED50 values): (-)epinephrine (20 nM) greater than (-)norepinephrine (90 nm) greater than phenylephrine (400 nM) greater than isoproterenol (6000 nM). The stimulatory effect of (-)epinephrine or phenylephrine is completely reversed by low concentrations of the alpha-adrenergic antagonist phentolamine while the beta-adrenergic antagonist propranolol has no effect up to 10 muM. Beside providing an easily accessible pure population of post-synaptic alpha-adrenergic receptors having potential applications as a model for other less accessible alpha-adrenergic brain systems, the present data suggest the possibility of the direct involvement of a catecholamine in the physiological control of ACTH secretion in the rat anterior pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114000     DOI: 10.1016/0303-7207(81)90038-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8.

Authors:  Nan Zhang; Jun-kai Lin; Juan Chen; Xiong-fei Liu; Jia-li Liu; Hao-shu Luo; Yue-qin Li; Sheng Cui
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

2.  Naltrexone effects on pituitary neurointermediate lobe and median eminence.

Authors:  L C Saland; E Reyes; E Ortiz
Journal:  Neurochem Res       Date:  1984-02       Impact factor: 3.996

3.  A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration.

Authors:  Peter W Marinelli; Rémi Quirion; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

4.  Alpha-1 adrenergic blockade: a possible mechanism of action of dopaminergic drugs on ACTH secretion.

Authors:  M Boscaro; A M Menegus; F Mantero
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

5.  Naloxone prevents the facilitatory effect upon retention induced by adrenaline administration in rats.

Authors:  S del Cerro; J Borrell
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.